Current possibilities for early diagnosis of systemic lupus erythematosus
https://doi.org/10.14412/1996-7012-2018-3-34-39
Abstract
The review presents the data available in the literature on the use of the lupus band test (LBT) for systemic lupus erythematosus (SLE). LBT is a direct immunofluorescence method used to detect immunoglobulins and complement factors in the dermoepidermal junction of skin biopsy specimens. LBT may be applied as one of the diagnostic tests for early diagnosis of SLE in patients without skin manifestations and in those of incomplete SLE. Like the results of other laboratory tests, those of LBT may be taken into account when establishing a final diagnosis only in conjunction with other clinical, immunological and instrumental data.
About the Authors
V. A. Lila
I.I. Mechnikov North-Western State Medical University, Ministry of Health of Russia
Russian Federation
Russian Federation
Viktoria Aleksandrovna Lila
41, Kirochnaya St., Saint Petersburg 191015
V. I. Mazurov
I.I. Mechnikov North-Western State Medical University, Ministry of Health of Russia
Russian Federation
41, Kirochnaya St., Saint Petersburg 191015
Russian Federation
41, Kirochnaya St., Saint Petersburg 191015
S. V. Lapin
Acad. I.P. Pavlov First Saint Petersburg State Medical University, Ministry of Health of Russia
Russian Federation
6–8, Lev Tolstoy St., Saint Petersburg 197022
Russian Federation
6–8, Lev Tolstoy St., Saint Petersburg 197022
A. V. Mazing
Acad. I.P. Pavlov First Saint Petersburg State Medical University, Ministry of Health of Russia
Russian Federation
6–8, Lev Tolstoy St., Saint Petersburg 197022
Russian Federation
6–8, Lev Tolstoy St., Saint Petersburg 197022
A. N. Moshnikova
Acad. I.P. Pavlov First Saint Petersburg State Medical University, Ministry of Health of Russia
Russian Federation
6–8, Lev Tolstoy St., Saint Petersburg 197022
Russian Federation
6–8, Lev Tolstoy St., Saint Petersburg 197022
References
1. Solov'ev SK Systemic lupus erythematosus. In: Nasonov EL, editor. Rossiiskie klinicheskie rekomendatsii. Revmatologiya [Russian clinical guidelines. Rheumatology]. Moscow: GEOTAR-Media; 2017. P. 113-36.
2. Klyukvina NG, Nasonov EL. The clinical and laboratory manifestation of systemic lupus erythematosus. Sovremennaya revmatologiya = Modern Rheumatology Journal. 2012;6(4):40-8 (In Russ.). Doi: 10.14412/1996-7012-2012-761
3. Lila AM, Trofimov EA, Lila VA. Systemic lupus erythematosus: Specific features of its course and therapy options. Sovremennaya revmatologiya = Modern Rheumatology Journal. 2015;9(3):43-7. (In Russ.). Doi: 10.14412/1996-7012-2015-343-47
4. Mazurov VI, editor. Diffuznye bolezni soedinitel'noi tkani: rukovodstvo dlya vrachei [Diffuse connective tissue diseases: a guide for physicians]. Saint-Petersburg: SpetsLit; 2009. 192 p.
5. Lapin SV, Totolyan AA. Immunologicheskaya laboratornaya diagnostika autoimmunnykh zabolevanii [Immunological laboratory diagnostics of autoimmune diseases]. Saint-Petersburg: Chelovek; 2010. 272 p.
6. Sozina AV. Kliniko-immunologicheskie vzaimosvyazi pri sistemnoi krasnoi volchanke i drugikh boleznyakh soedinitel'noi tkani. Autoref. diss. cand. med. sci. Saint-Petersburg; 2007. 22 p.
7. Beutner EH, Holborow EJ, Johnson GD. A new fluorescent antibody method: Mixed antiglobulin immunofluorescence or labelled antigen indirect immunofluorescence staining. Nature. 1965 Oct 23;208(5008):353-5.
8. Burnham TK, Neblett TR, Fine G. Immunofluorescent «band» test for lupus erythematosus. II. Employing skin lesions. Arch Dermatol. 1970 Jul;102(1):42-50.
9. Cormane RH. «Bound» globulin in the skin of patients with chronic discoid lupus erythematosus and systemic lupus erythematosus. Lancet. 1964 Mar 7;1(7332):534-5.
10. Crowson AN, Magro CM. Cutaneous histopathology of lupus erythematosus. Diagn Histopathol. 2009;15:157–85.
11. Meurer M. Immunopathology of cutaneous lupus erythematosus. In: Kuhn A, Lehmann P, Ruzicka T, editros. Cutaneous Lupus Erythematosus. Springer-Verlag: Berlin; 2005. P.305-10.
12. Gilliam JN. The significance of cutaneous immunoglobulin deposits in lupus erythematosus and NZB/NZW F1 hybrid mice. J Invest Dermatol. 1975 Jul;65(1):154-61.
13. Meurer M, Gigli J. Interaction of DNA with the early components of complement. J Invest Dermatol. 1978;70:223.
14. Gangaram HB, Kong NC, Phang KS, Suraiya H. Lupus band test in systemic lupus erythematosus. Med J Malaysia. 2004 Dec;59(5):638-48.
15. Casciola-Rosen L, Rosen L. Ultraviolet light-induced apoptosis: a potential mechanism for the induction of skin lesions and autoantibody production in LE. Lupus. 1997;6(2):175-80.
16. Reich A, Meurer M, Viehweg A, Muller DJ. Narrow-band UVB induced externalization of selected nuclear antigens in keratinocytes: implications for lupus erythematosus pathogenesis. Photochem Photobiol. 2009 Jan-Feb;85(1):1-7. doi: 10.1111/j.17511097.2008.00480.x. Epub 2008 Dec 8.
17. Ahmed AR, Provost TT. The incidence of a positive lupus band test using sun-exposed and unexposed skin. Arch Dermatol. 1979 Feb;115(2):228-9.
18. Dahl MV. Usefulness of direct immunofluorescence in patients with lupus erythematosus. Arch Dermatol. 1983 Dec;119(12):1010-7.
19. Reich A, Marcinow K, Bialynicki-Birula R. The lupus band test in systemic lupus erythematosus patients. Ther Clin Risk Manag. 2011 Jan 24;7:27-32. doi: 10.2147/TCRM.S10145.
20. Sontheimer RD, Provost TT. Cutaneous manifestations of lupus erythematosus. In: Wallace DJ, Hahn BH, editors. Dubois’ lupus erythematosus. 5th ed. Baltimore: Williams & Wilkins; 1997. P. 569–623.
21. Cardinali C, Caproni M, Fabbri P. The composition of the lupus band test (LBT) on the sun protected non lesional (SPNL) skin in patients with cutaneous lupus erythematosus (CLE). Lupus. 1999;8(9):755-60.
22. Wojnarowska F, Bhogal B, Black MM. The significance of an IgM band at the dermo-epidermal junction. J Cutan Pathol. 1986 Oct;13(5):359-62.
23. Mehta V, Sarda A, Balachandran C. Lupus band test. Indian J Dermatol Venereol Leprol. 2010 May-Jun;76(3):298-300. doi: 10.4103/0378-6323.62983.
24. Mysorekar VV, Sumathy TK, Shyam Prasad AL. Role of direct immunofluorescence in dermatological disorders. Indian Dermatol Online J. 2015 May-Jun;6(3):17280. doi: 10.4103/2229-5178.156386.
25. Provost TT, Andres G, Maddison PJ, Reichlin M. Lupus band test in untreated SLE patients: correlation of immunoglobulin deposition in the skin of the extensor forearm with clinical renal disease and serological abnormalities. J Invest Dermatol. 1980 Jun;74(6):407-12.
26. Burnham TK, Fine G. The immunofluorescent «band» test for lupus erythematosus. I. Morphologic variations of the band of localized immunoglobulins at the dermal-epidermal junction in lupus erythematosus. Arch Dermatol. 1969 Apr;99(4):413-20.
27. Sontheimer RD, Gilliam JN. A reappraisal of the relationship between subepidermal immunoglobulin deposits and DNA antibodies in systemic lupus erythematosus: a study using the crithidia lucillae immunofluorescence anti-DNA assay. J Invest Dermatol. 1979 Jan;72(1):29-32.
28. Carvalho MF, Coelho RA. Lupus band test: diagnostic value in disseminated lupus erythematosus. Acta Med Port. 1991 SepOct;4(5):242-8.
29. Burnham TK, Fine G. The immunofluorescent «band» test for lupus erythematosus. 3. Employing clinically normal skin. Arch Dermatol. 1971 Jan;103(1):24-32.
30. Leibold AM, Bennion S, David-Bajar K, Schleve MJ. Occurrence of positive immunofluorescence in the dermoepidermal junction of sun-exposed skin of normal adults. J Cutan Pathol. 1994 Jun;21(3):200-6.
31. Fabre VC, Lear S, Reichlin M, et al. Twenty percent of biopsy specimens from sun-exposed skin of normal young adults demonstrate positive immunofluorescence. Arch Dermatol. 1991 Jul;127(7):1006-11.
32. Liu T, Liu FR. Prognostic value of lupus band test in unexposed normal skin of patients with systemic lupus erythematosus. Chin Med J (Engl). 1989 Aug;102(8):620-4.
33. Halberg P, Ullman S, Jorgensen F. The lupus band test as a measure of disease activity in systemic lupus erythematosus. Arch Dermatol. 1982 Aug;118(8):572-6.
34. Crowson AN, Magro C. The cutaneous pathology of lupus erythematosus: a review. J Cutan Pathol. 2001 Jan;28(1):1-23.
35. Magro CM, Crowson AN. The immunofluorescent profile of dermatomyositis. A comparative study with lupus erythematosus. J Cutan Pathol. 1997 Oct;24(9):543-52.
36. Shibeshi D, Blaszczyk M, JarzabekChorzelska M, et al. Immunopathologic findings in systemic sclerosis patients: clinical and immunopathologic relationships. Int J Dermatol. 1989 Dec;28(10):650-6.
37. Davis BM, Gilliam AN. Prognostic significance of subepidermal immune deposits in uninvolved skin of patients with systemic lupus erythematosus: 10 year longitudinal study. J Invest Dermatol. 1984 Oct;83(4):242-7.
38. Zecevic RD, Pavlovic MD, Stefanovic D. Lupus band test and disease activity in systemic lupus erythematosus: does it still matter. Clin Exp Dermatol. 2006 May;31(3):358-60.
Review
For citations:
Lila VA, Mazurov VI, Lapin SV, Mazing AV, Moshnikova AN. Current possibilities for early diagnosis of systemic lupus erythematosus. Sovremennaya Revmatologiya=Modern Rheumatology Journal. 2018;12(3):34-39. (In Russ.) https://doi.org/10.14412/1996-7012-2018-3-34-39
Views:
2440
Email this article 